TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
Data as of , from SEC Form 4 filings.
Net insider selling (90d)Watch TEVA
See up to 3 months of TEVA. The 7-day demo opens the 1M and 3M ranges and puts TEVA on your watchlist.
Start 7-day demoLatest TEVA insider trades
About TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
TEVA PHARMACEUTICAL INDUSTRIES LTD is an SEC registrant, filing under CIK 0000818686, classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
TEVA Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 11 | 441,824 | $17.03M |
| Option exercise | 8 | 145,148 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
TEVA insider transactions (Form 4)
5491 Form 4 filings on record, the earliest from Nov 21, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Brian Savage - Officer | Option exercise | Ordinary Shares | 4,503 | $34.70 | $156K | |
| Brian Savage - Officer | Open-market sale | Ordinary Shares | 4,503 | $38.69 | $174K | |
| Brian Savage - Officer | Open-market sale | Ordinary Shares | 2,525 | $39.15 footnote F1 | $99K | |
| Brian Savage - Officer | Open-market sale | Ordinary Shares | 314 | $38.70 | $12K | |
| Brian Savage - Officer | Option exercise | Stock Options (right to buy) | 4,503 | $34.70 | $156K | |
| ||||||
| Roberto Mignone - Director | Open-market sale | Ordinary Shares | 367,600 | $39.06 footnote F1 | $14.36M | |
| ||||||
| Amir Weiss - Officer | Open-market sale | Ordinary Shares | 6,945 | $37.61 footnote F2 | $261K | |
| Amir Weiss - Officer | Option exercise | Ordinary Shares | 2,500 | $19.61 | $49K | |
| Amir Weiss - Officer | Open-market sale | Ordinary Shares | 2,500 | $37.63 | $94K | |
| Amir Weiss - Officer | Option exercise | Stock Options (right to buy) | 2,500 | $19.16 | $48K | |
| ||||||
| Ronit Satchi-Fainaro - Director | Open-market sale | Ordinary Shares | 415 | $37.25 | $15K | |
| Evan Lippman - Officer | Open-market sale | Ordinary Shares | 18,600 | $36.57 footnote F3 | $680K | |
| ||||||
 Tal Zvi Zaks - Director | Open-market sale | Ordinary Shares | 17 | $34.87 | $593 | |
| Placid Jover - Officer | Option exercise | Ordinary Shares | 12,827 | - footnote F2 | - | |
| Placid Jover - Officer | Open-market sale | Ordinary Shares | 12,827 footnote F4 | $34.88 footnote F5 | $447K | |
| Placid Jover - Officer | Option exercise | Restricted Share Units | 12,827 | $0.00 | - | |
| ||||||
| Eric A. Hughes - Officer | Option exercise | Ordinary Shares | 52,744 | - footnote F2 | - | |
| Eric A. Hughes - Officer | Open-market sale | Ordinary Shares | 25,578 footnote F4 | $34.88 footnote F5 | $892K | |
| Eric A. Hughes - Officer | Option exercise | Restricted Share Units | 52,744 | $0.00 | - | |
| ||||||
| Matthew Shields - Officer | Open-market sale | Ordinary Shares | 9,989 | $32.19 | $322K | |
| Eliyahu Sharon Kalif - Officer | Open-market sale | Ordinary Shares | 106,563 | $34.10 footnote F3 | $3.63M | |
| ||||||
| Sol J. Barer | Option exercise | Ordinary Shares | 21,739 | - footnote F2 | - | |
| Sol J. Barer | Option exercise | Restricted Share Units | 21,739 | $0.00 | - | |
| ||||||
| Chen Lichtenstein | Option exercise | Ordinary Shares | 14,492 | - footnote F2 | - | |
| Chen Lichtenstein | Option exercise | Restricted Share Units | 14,492 | $0.00 | - | |
| ||||||
 Rosemary A. Crane | Option exercise | Ordinary Shares | 14,492 | - footnote F2 | - | |
| Rosemary A. Crane | Option exercise | Restricted Share Units | 14,492 | $0.00 | - | |
| ||||||
 Amir Elstein | Option exercise | Ordinary Shares | 14,492 | - footnote F2 | - | |
| Amir Elstein | Option exercise | Restricted Share Units | 14,492 | $0.00 | - | |
| ||||||
| Gerald M. Lieberman | Option exercise | Ordinary Shares | 14,492 | - footnote F2 | - | |
| Gerald M. Lieberman | Option exercise | Restricted Share Units | 14,492 | $0.00 | - | |
| ||||||
| Perry Nisen | Option exercise | Ordinary Shares | 14,492 | - footnote F2 | - | |
| Perry Nisen | Option exercise | Restricted Share Units | 14,492 | $0.00 | - | |
| ||||||
| Ronit Satchi-Fainaro | Option exercise | Ordinary Shares | 14,492 | - footnote F2 | - | |
| Ronit Satchi-Fainaro | Option exercise | Restricted Share Units | 14,492 | $0.00 | - | |
| ||||||
| Tal Zvi Zaks | Option exercise | Ordinary Shares | 14,492 | - footnote F2 | - | |
| Tal Zvi Zaks | Option exercise | Restricted Share Units | 14,492 | $0.00 | - | |
| ||||||
| Roberto Mignone | Option exercise | Ordinary Shares | 14,492 | - footnote F2 | - | |
| Roberto Mignone | Option exercise | Restricted Share Units | 14,492 | $0.00 | - | |
| ||||||
| Richard D. Francis - Officer | Option exercise | Ordinary Shares | 13,043 | - footnote F2 | - | |
| Richard D. Francis - Officer | Open-market sale | Ordinary Shares | 6,153 footnote F4 | $34.35 | $211K | |
| Richard D. Francis - Officer | Option exercise | Restricted Share Units | 13,043 | $0.00 | - | |
| ||||||
| Matthew Shields - Officer | Option exercise | Ordinary Shares | 16,195 | - footnote F2 | - | |
| Matthew Shields - Officer | Open-market sale | Ordinary Shares | 16,195 footnote F4 | $32.87 | $532K | |
| Matthew Shields - Officer | Option exercise | Restricted Share Units | 16,195 | $0.00 | - | |
| ||||||
| Tal Zvi Zaks | Grant or award | Restricted Share Units | 7,242 | $0.00 | - | |
| Ronit Satchi-Fainaro | Grant or award | Restricted Share Units | 7,242 | $0.00 | - | |
| Perry Nisen | Grant or award | Restricted Share Units | 7,242 | $0.00 | - | |
| Gerald M. Lieberman | Grant or award | Restricted Share Units | 7,242 | $0.00 | - | |
| Amir Elstein | Grant or award | Restricted Share Units | 7,242 | $0.00 | - | |
| Rosemary A. Crane | Grant or award | Restricted Share Units | 7,242 | $0.00 | - | |
| Chen Lichtenstein | Grant or award | Restricted Share Units | 7,242 | $0.00 | - | |
| Sol J. Barer | Grant or award | Restricted Share Units | 10,863 | $0.00 | - | |
| Roberto Mignone | Grant or award | Restricted Share Units | 7,242 | $0.00 | - | |
Item 1.01, 2.03, 9.01
Item 8.01
Item 7.01, 8.01, 9.01
Item 8.01, 9.01
Recent TEVA Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Savage Brian | Officer, CHIEF LEGAL OFFICER | 7,028 | $273K | View on EDGAR | |
| Bridger Management, LLC (1) | Shareholder | 367,600 |
TEVA insider trading FAQ
What is the latest insider trade for TEVA?
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) had 8 insider filings in the last 90 days, with the most recent on 2026-09-22. The full record for TEVA runs to 91 Form 4 filings, the earliest from 2024-11-21. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying TEVA stock?
No insider purchases of TEVA were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling TEVA stock?
11 insider sales of TEVA were filed in the last 90 days, totaling $17.03M.
Where can I see TEVA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects TEVA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Brian Savage view on EDGAR
- - Roberto Mignone view on EDGAR
- - Amir Weiss view on EDGAR
- - Ronit Satchi-Fainaro view on EDGAR
- - Evan Lippman view on EDGAR
- - Tal Zvi Zaks view on EDGAR
- - Placid Jover view on EDGAR
- - Eric A. Hughes view on EDGAR
- - Matthew Shields view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where TEVA's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow TEVA with a 7-day demo
- TEVA on your watchlist
- Every TEVA Form 4 filing on record
- Up to 3 months of TEVA price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
